GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GlycoMimetics Inc (FRA:GKO) » Definitions » Price-to-Funds-From-Operations

GlycoMimetics (FRA:GKO) Price-to-Funds-From-Operations : (As of May. 16, 2024)


View and export this data going back to 2014. Start your Free Trial

What is GlycoMimetics Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


GlycoMimetics (FRA:GKO) Business Description

Industry
Traded in Other Exchanges
Address
9708 Medical Center Drive, Rockville, MD, USA, 20850
GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection.